BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33895085)

  • 1. Adeno-Associated Virus Vector for Central Nervous System Gene Therapy.
    Zhu D; Schieferecke AJ; Lopez PA; Schaffer DV
    Trends Mol Med; 2021 Jun; 27(6):524-537. PubMed ID: 33895085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-Associated Virus-Based Gene Therapy for CNS Diseases.
    Hocquemiller M; Giersch L; Audrain M; Parker S; Cartier N
    Hum Gene Ther; 2016 Jul; 27(7):478-96. PubMed ID: 27267688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
    Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
    J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy and neurodevelopmental disorders.
    Gray SJ
    Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
    Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
    Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus vector as a platform for gene therapy delivery.
    Wang D; Tai PWL; Gao G
    Nat Rev Drug Discov; 2019 May; 18(5):358-378. PubMed ID: 30710128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications involving CNS gene transfer.
    Kantor B; McCown T; Leone P; Gray SJ
    Adv Genet; 2014; 87():71-124. PubMed ID: 25311921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus (AAV) vectors in cancer gene therapy.
    Santiago-Ortiz JL; Schaffer DV
    J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-Associated Virus (AAV) Vectors in the CNS.
    McCown TJ
    Curr Gene Ther; 2011 Jun; 11(3):181-8. PubMed ID: 21453285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice.
    Hinderer C; Katz N; Louboutin JP; Bell P; Yu H; Nayal M; Kozarsky K; O'Brien WT; Goode T; Wilson JM
    Hum Gene Ther; 2016 Nov; 27(11):906-915. PubMed ID: 27510804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.
    Hinderer C; Bell P; Katz N; Vite CH; Louboutin JP; Bote E; Yu H; Zhu Y; Casal ML; Bagel J; O'Donnell P; Wang P; Haskins ME; Goode T; Wilson JM
    Hum Gene Ther; 2018 Jan; 29(1):15-24. PubMed ID: 28806897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus (AAV) vectors in the CNS.
    McCown TJ
    Curr Gene Ther; 2005 Jun; 5(3):333-8. PubMed ID: 15975010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs.
    Leong TW; Pal A; Cai Q; Gao Z; Li X; Bleris L; Hayenga HN; Qin Z
    J Control Release; 2023 May; 357():511-530. PubMed ID: 37040842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system.
    Ruitenberg MJ; Eggers R; Boer GJ; Verhaagen J
    Methods; 2002 Oct; 28(2):182-94. PubMed ID: 12413416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vectors for gene delivery to the central nervous system.
    Lentz TB; Gray SJ; Samulski RJ
    Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches.
    Prasad S; Dimmock DP; Greenberg B; Walia JS; Sadhu C; Tavakkoli F; Lipshutz GS
    Hum Gene Ther; 2022 Dec; 33(23-24):1228-1245. PubMed ID: 35994385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal Delivery of AAV Vectors in Cynomolgus Macaques for CNS Gene Therapy and Gene Expression Analysis in Microdissected Motor Neurons.
    Borel F; Adams E; Mueller C
    Methods Mol Biol; 2019; 1937():295-303. PubMed ID: 30706405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.